GlassScriptPhysician profile
Donna Stubbs
NPI 1538134705
$3,330.76
in general payments reported to CMS, 2019-2025
28 companies · $697 in 2025
The $697 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $147 · 2022: $249 · 2023: $1,160 · 2024: $1,077 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,910 · Education: $24.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,909.58 |
| Education | $24.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $524.91 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $495.30 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $318.65 | 2023-2025 | |
| Astellas Pharma US INC | $314.27 | 2021-2024 | Myrbetriq, Veozah, Xtandi |
| Amgen INC. | $232.37 | 2024 | Krystexxa, Evenity |
| Janssen Biotech, INC. | $202.39 | 2022-2024 | Erleada |
| Tolmar, INC. | $138.43 | 2023-2024 | |
| Endo Pharmaceuticals INC. | $114.42 | 2021-2024 | Xiaflex, Aveed |
| Alexion Pharmaceuticals, INC. | $112.51 | 2025 | |
| Ferring Pharmaceuticals INC. | $107.95 | 2024-2025 | Adstiladrin |
| Telix Pharmaceuticals | $96.05 | 2023 | Illuccix |
| Progenics Pharmaceuticals, INC. | $92.86 | 2024-2025 | |
| Endo USA, INC. | $87.46 | 2024-2025 | Xiaflex, Aveed |
| Boston Scientific Corporation | $72.81 | 2024-2025 | Ams 700 |
| Merck Sharp & Dohme LLC | $63.39 | 2021-2024 | Keytruda, Lynparza |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $55.21 | 2022-2024 | |
| Baxter Healthcare | $43.81 | 2023 | Tisseel |
| Dendreon Pharmaceuticals LLC | $43.04 | 2023 | Provenge |
| Convatec INC. | $36.08 | 2023 | |
| Calyxo, INC. | $24.76 | 2025 | Cvac Aspiration System |
| Urogen Pharma, INC. | $23.35 | 2025 | |
| Urovant Sciences INC | $21.98 | 2022 | |
| Olympus America INC. | $20.45 | 2023 | Itind System |
| Teleflex LLC | $19.11 | 2022 | |
| Medtronic, INC. | $18.18 | 2022 | |
| Supreme Orthopedic Systems, LLC | $17.21 | 2023 | |
| Photocure INC | $17.18 | 2025 | Cysview |
| Coloplast Corp | $16.63 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Stubbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.